Atlas Legacy Advisors LLC Purchases Shares of 2,154 UnitedHealth Group Incorporated (NYSE:UNH)

Atlas Legacy Advisors LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,154 shares of the healthcare conglomerate's stock, valued at approximately $1,090,000.

A number of other hedge funds have also recently made changes to their positions in the business. Jmac Enterprises LLC raised its stake in shares of UnitedHealth Group by 2.2% in the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate's stock worth $481,000 after purchasing an additional 18 shares during the last quarter. Wallace Capital Management Inc. boosted its holdings in UnitedHealth Group by 0.9% during the 3rd quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate's stock worth $1,239,000 after acquiring an additional 19 shares during the last quarter. Western Pacific Wealth Management LP raised its holdings in shares of UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock valued at $456,000 after purchasing an additional 19 shares during the last quarter. JNBA Financial Advisors boosted its holdings in UnitedHealth Group by 0.4% during the third quarter. JNBA Financial Advisors now owns 4,686 shares of the healthcare conglomerate's stock worth $2,740,000 after purchasing an additional 20 shares during the last quarter. Finally, Paragon Capital Management LLC increased its stake in UnitedHealth Group by 2.9% in the 3rd quarter. Paragon Capital Management LLC now owns 721 shares of the healthcare conglomerate's stock valued at $422,000 after buying an additional 20 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on UNH. Wells Fargo & Company decreased their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Barclays reduced their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Finally, KeyCorp reaffirmed an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Price Performance

NYSE UNH traded down $36.84 during trading on Friday, reaching $465.58. The company's stock had a trading volume of 19,847,353 shares, compared to its average volume of 4,805,500. The stock has a market capitalization of $428.46 billion, a PE ratio of 30.04, a P/E/G ratio of 1.40 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a fifty day moving average of $520.37 and a 200 day moving average of $561.26. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the business posted $5.83 earnings per share. UnitedHealth Group's revenue for the quarter was up 6.8% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.